The University of Chicago Header Logo

Connection

Jonathan Moss to Bevacizumab

Back to Details
This is a "connection" page, showing publications Jonathan Moss has written about Bevacizumab.
Jonathan Moss
Connection Strength
0.071
Bevacizumab
  1. Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. Mol Cancer Ther. 2008 Jun; 7(6):1669-79.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.